Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Watch EHA2024: Cold Agglutinin Disease in the Clinic
June 2024
Watch this EHA2024 Satelite Symposium exploring the disease burden of CAD beyond anemia by examining its influence on day-to-day life and…
Read more
20th August 2022
Increasing Awareness in Beta-Thalassemia
This series of webinars focusses on Beta-Thalassemia. These are scientific presentations and discussions for the purpose of scientific exchange.
16th August 2022
Is Complete Response Enough? An Expert Look Towards the Future of Higher-Risk MDS Treatment
This satellite symposium discusses current key topics in higher-risk MDS, including treatment outcome measures
21st July 2022
New Treatment Options in Paediatric Thalassemia
The third of our six-part series focuses on new treatment options in paediatric thalassemia with expert Dr Immacolata Tartaglione, paediatrician at University of Campania Luigi Vanvitelli in Napoli, Italy.
31st May 2022
Novel targets for therapy in TD β-Thalassaemia
The second of our six-part series focusing on increasing awareness of β-thalassaemia features Khaled Musallam, Clinical Professor at…
25th May 2022
CME-Accredited Webinar on Biosimilars within Haematology & Oncology
This presidential debate-style discussion explores the topic of biosimilars within haematology and oncology.
13th May 2022
Jazz-Sponsored Symposium - High-risk AML* in 2022: what is the go-to strategy?
*High-risk AML defined as therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC)
28th April 2022
Clinical Challenges and Limitations in β-Thalassaemia Treatment and Their Impact on Patient Outcomes
Cappellini shares her expert insights into β-thalassaemia with our chair, internationally renowned surgeon Jonathan Sackier. With a focus…
30th September 2021
ESMO 2021 Jazz Pharmaceuticals AML symposium
Insight beyond Phase 3: Does real-world evidence impact how we treat high-risk AML…
Loading posts...
« Previous
1
2
3
4
5
…
8
Next »